首页> 外文期刊>World Journal of Gastroenterology >Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B.
【24h】

Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B.

机译:T细胞对HBcAg反应低下的机制与慢性乙型肝炎的调节性T细胞有关。

获取原文
获取原文并翻译 | 示例
       

摘要

AIM: To study the mechanisms of hyporesponsiveness of HBV-specific CD4+ T cells by testing TH1 and TH2 commitment and regulatory T cells. METHODS: Nine patients with chronic hepatitis B were enrolled. Peripheral blood mononuclear cells were stimulated with HBcAg or HBsAg to evaluate their potential to commit to TH1 and TH2 differentiation. HBcAg-specific activity of regulatory T cells was evaluated by staining with antibodies to CD4, CD25, CTLA-4 and interleukin-10. The role of regulatory T cells was further assessed by treatment with anti-interleukin-10 antibody and depletion of CD4+CD25+ cells. RESULTS: Level of mRNAs for T-bet, IL-12R beta2 and IL-4 was significantly lower in the patients than in healthy subjects with HBcAg stimulation. Although populations of CD4+CD25highCTLA-4+ T cells were not different between the patients and healthy subjects, IL-10 secreting cells were found in CD4+ cells and CD4+CD25+ cells in the patients in response to HBcAg, and they were not found in cells which were stimulated with HBsAg. Addition of anti-IL-10 antibody recovered the amount of HBcAg-specific TH1 antibody compared with control antibody (P < 0.01, 0.34% +/- 0.12% vs 0.15% +/- 0.04%). Deletion of CD4+CD25+ T cells increased the amount of HBcAg-specific TH1 antibody when compared with lymphocytes reconstituted using regulatory T cells (P < 0.01, 0.03% +/- 0.02% vs 0.18% +/- 0.05%). CONCLUSION: The results indicate that the mechanism of T cell hyporesponsiveness to HBcAg includes activation of HBcAg-induced regulatory T cells in contrast to an increase in TH2-committed cells in response to HBsAg.
机译:目的:通过测试TH1和TH2水平以及调节性T细胞,研究HBV特异性CD4 + T细胞反应低下的机制。方法:9例慢性乙型肝炎患者入选。用HBcAg或HBsAg刺激外周血单核细胞,以评估其参与TH1和TH2分化的潜力。通过用针对CD4,CD25,CTLA-4和白细胞介素10的抗体染色来评估调节性T细胞的HBcAg特异性活性。通过用抗白介素10抗体治疗和消耗CD4 + CD25 +细胞,进一步评估了调节性T细胞的作用。结果:患者的T-bet,IL-12R beta2和IL-4的mRNA水平显着低于接受HBcAg刺激的健康受试者。尽管患者和健康受试者之间CD4 + CD25highCTLA-4 + T细胞的数量没有差异,但患者对HBcAg的反应在CD4 +细胞和CD4 + CD25 +细胞中发现了IL-10分泌细胞,而在HBcAg中却没有发现。 HBsAg刺激的细胞。与对照抗体相比,添加抗IL-10抗体可回收HBcAg特异性TH1抗体的量(P <0.01,0.34%+/- 0.12%对0.15%+/- 0.04%)。与使用调节性T细胞重建的淋巴细胞相比,CD4 + CD25 + T细胞的缺失增加了HBcAg特异性TH1抗体的量(P <0.01,0.03%+/- 0.02%对0.18%+/- 0.05%)。结论:结果表明,T细胞对HBcAg反应低下的机制包括激活HBcAg诱导的调节性T细胞,而TH2定型细胞对HBsAg的反应却有所增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号